Appropriateness of drug dose and frequency in patients with renal dysfunction in a tertiary care hospital: A cross-sectional study

Journal of Pharmacy and Bioallied Sciences

Volumn 5, Issue 2, 2013, Pages 136-140

  Prajapati, Arpit ^a   Ganguly, Barna ^b  

^a Lambda Therapeut Research Pvt Ltd   (India)

^b Pramukh Swami Medical College   (India)

Author keywords

Chronic kidney disease; clearance; creatinine; dose adjustment

Indexed keywords

AMOXICILLIN; ANALGESIC AGENT; ANTIALLERGIC AGENT; ANTIINFECTIVE AGENT; CARDIOVASCULAR AGENT; CIPROFLOXACIN; DIGOXIN; FAMOTIDINE; GASTROINTESTINAL AGENT; LEVOFLOXACIN; PARACETAMOL; PIPERACILLIN;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DOSE ADJUSTMENT; DRUG DOSE; DRUG FREQUENCY; DRUG USE; FEMALE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE;

EID: 84878523795     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.111829     Document Type: Article

References (23)

1. van Dijk EA, Drabbe NR, Kruijtbosch M, De Smet PA. Drug dosage adjustments according to renal function at hospital discharge. Ann Pharmacother 2006;40:1254-60. (Pubitemid 44204953)
2. Pillans PI, Landsberg PG, Fleming AM, Fanning M, Sturtevant JM. Evaluation of dosage adjustment in patients with renal impairment. Intern Med J 2003;33:10-3. (Pubitemid 36241568)
3. Salomon L, Deray G, Jaudon MC, Chebassier C, Bossi P, Launay-Vacher V, et al. Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care 2003;15:331-5. (Pubitemid 36987271)
4. Salomon L, Levu S, Deray G, Launay-Vacher V, Brücker G, Ravaud P. Assessing residents' prescribing behavior in renal impairment. Int J Qual Health Care 2003;15:235-40. (Pubitemid 36675719)
5. Long CL, Raebel MA, Price DW, Magid DJ. Compliance with dosing guidelines in patients with chronic kidney disease. Ann Pharmacother 2004;38:853-8. (Pubitemid 38509067)
6. van Dijk EA, Drabbe NR, Kruijtbosch M, De Smet PA. Dosage adjustments according to renal function at discharge: A comparison of 3 hospitals. Ann Pharmacother 2006;40:2276-7. (Pubitemid 44954455)
7. Munar MY, Singh H. Drug dosing adjustments in patients with chronic kidney disease. Am Fam Physician 2007;75:1487-96. (Pubitemid 46790332)
8. Peterson JP, Colucci VJ, Schiff SE. Using serum creatinine concentrations to screen for inappropriate dosage of renally eliminated drugs. Am J Hosp Pharm 1991;48:1962-4.
9. Goldberg DE, Baardsgaard G, Johnson MT, Jolowsky CM, Shepherd M, Peterson CD. Computer-based program for identifying medication orders requiring dosage modification based on renal function. Am J Hosp Pharm 1991;48:1965-9.
10. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997;277:307-11. (Pubitemid 27045011)
11. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997;277:301-6. (Pubitemid 27045010)
12. Aronoff GR, Berns JS, Brier ME, Golper TA, Morrison G, Singer I, et al. Drug prescribing in renal failure: Dosing Guidelines for Adults. 4 th ed. Michigan: American College of Physicians; 1999.
13. Taeschner W, Vozeh S. Pharmacokinetic drug data. In: Speight TM, Holford NH, editors. Avery's Drug Treatment. 4 th ed. Auckland: Adis International; 1997. p. 1629-64.
14. Markota NP, Markota I, Tomic M, Zelenika A. Inappropriate drug dosage adjustments in patients with renal impairment. J Nephrol 2009;22:497-501.
15. Matzke GR, Frye RF. Drug therapy individualization for patients with renal insufficiency. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy: A Pathophysiological Approach. 7 th ed. New York: McGraw Hill Companies; 2008. p. 833-44.
16. Sweileh WM, Janem SA, Sawalha AF, Abu-Taha AS, Zyoud SH, Sabri IA, et al. Medication dosing errors in hospitalized patients with renal impairment: A study in Palestine. Pharmacoepidemiol Drug Saf 2007;16:908-12. (Pubitemid 47333542)
17. Blix HS, Viktil KK, Moger TA, Reikvam A. Use of renal risk drugs in hospitalized patients with impaired renal function-an underestimated problem? Nephrol Dial Transplant 2006;21:3164-71. (Pubitemid 44567089)
18. Soetikno V, Effendi I, Nafrialdi, Setiabudy R. A survey on the appropriateness of drug therapy in patients with renal dysfunction at the internal medicine ward FMUI/Dr. Cipto Mangunkusumo Hospital. Med J Indones 2009;18:108-13.
19. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
20. Matzke GR, Frye RF. Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity. Drug Saf 1997;16:205-31. (Pubitemid 27145966)
21. Tett SE, Kirkpatrick CM, Gross AS, McLachlan AJ. Principles and clinical application of assessing alterations in renal elimination pathways. Clin Pharmacokinet 2003;42:1193-211. (Pubitemid 37491486)
22. Swan SK, Bennett WM. Drug dosing guidelines in patients with renal failure. West J Med 1992;156:633-8.
23. Kappel J, Calissi P. Nephrology: 3. Safe drug prescribing for patients with renal insufficiency. CMAJ 2002;166:473-7. (Pubitemid 34164099)